ReviewFrontiers in pharmacology2026
The biology, function, and applications of exosomes as novel biomarkers for
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Exosomes have become one of the hotspots in life science research in recent years. As an important carrier of bio-information substances, they can mediate intercellular communication by carrying various bioactive substances, thereby activating specific signal transduction pathways within cells and ultimately regulating cell phenotypes and functions. Among the abundant cargoes carried by exosomes, drug-metabolizing enzymes have gradually attracted increasing attention from researchers. More and more evidence suggests that the abundance and activity levels of these specific drug-metabolizing enzymes encapsulated in exosomes can often reflect the dynamic gene expression in their parent cells, which is of great significance for studying inter-individual variability in drug exposure. Based on this, this article reviews the biological origin of exosomes, related regulatory programs, their potential as biomarkers indicating
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.